Lee's Pharmaceutical Holdings Limited, through its subsidiary Nova Pneuma Inc., acquires the Staccato® One Breath Technology® platform and related assets from Alexza Pharmaceuticals, including intellectual property, trademarks, product pipeline, equipment, and manufacturing rights for Staccato® alprazolam under a global partnership with UCB.
Related articles
Press ReleaseMay 8, 2026
West Enclave Merger Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing May 13, 2026
May 8, 2026
Press ReleaseMay 8, 2026
Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)
May 8, 2026
Press ReleaseMay 8, 2026
Con Edison Announces $2 Billion At-The-Market (ATM) Equity Offering Program
May 8, 2026
← Back to all articles
Generated by Yeal